BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

642 related articles for article (PubMed ID: 17153868)

  • 1. [Feces culture successful therapy in Clostridium difficile diarrhea].
    Jorup-Rönström C; Håkanson A; Persson AK; Midtvedt T; Norin E
    Lakartidningen; 2006 Nov 15-21; 103(46):3603-5. PubMed ID: 17153868
    [No Abstract]   [Full Text] [Related]  

  • 2. Comparison of clinical and microbiological response to treatment of Clostridium difficile-associated disease with metronidazole and vancomycin.
    Al-Nassir WN; Sethi AK; Nerandzic MM; Bobulsky GS; Jump RL; Donskey CJ
    Clin Infect Dis; 2008 Jul; 47(1):56-62. PubMed ID: 18491964
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fecal transplant via retention enema for refractory or recurrent Clostridium difficile infection.
    Kassam Z; Hundal R; Marshall JK; Lee CH
    Arch Intern Med; 2012 Jan; 172(2):191-3. PubMed ID: 22271132
    [No Abstract]   [Full Text] [Related]  

  • 4. [Clostridium difficile--unfairly set in the corner?].
    Benno P; Dahlgren AL; Norin E; Midtvedt T
    Lakartidningen; 2012 Sep 26-Oct 9; 109(39-40):1775. PubMed ID: 23097893
    [No Abstract]   [Full Text] [Related]  

  • 5. Artificial stool transplantation: progress towards a safer, more effective and acceptable alternative.
    Allen-Vercoe E; Petrof EO
    Expert Rev Gastroenterol Hepatol; 2013 May; 7(4):291-3. PubMed ID: 23639085
    [No Abstract]   [Full Text] [Related]  

  • 6. [Clostridium difficile-associated diarrhea treated with homologous feces].
    Midtvedt K
    Tidsskr Nor Laegeforen; 1998 Apr; 118(11):1758. PubMed ID: 9621767
    [No Abstract]   [Full Text] [Related]  

  • 7. The changing face of Clostridium difficile: what treatment options remain?
    Shen EP; Surawicz CM
    Am J Gastroenterol; 2007 Dec; 102(12):2789-92. PubMed ID: 18042108
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Clostridium-difficile-associated diarrhea].
    Bujanda L; Cosme A
    Gastroenterol Hepatol; 2009 Jan; 32(1):48-56. PubMed ID: 19174100
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Role of Clostridium difficile infection in the relapse of ulcerative colitis].
    Vilalta Castel E; Alcázar Montero MS; Navarro Gaspar C; Gimeno Aranguez M
    An Med Interna; 2002 Dec; 19(12):637-9. PubMed ID: 12593034
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Decreased effectiveness of metronidazole for the treatment of Clostridium difficile infection?
    Kuijper EJ; Wilcox MH
    Clin Infect Dis; 2008 Jul; 47(1):63-5. PubMed ID: 18491959
    [No Abstract]   [Full Text] [Related]  

  • 11. Outcomes of Clostridium difficile-associated disease treated with metronidazole or vancomycin before and after the emergence of NAP1/027.
    Pépin J; Valiquette L; Gagnon S; Routhier S; Brazeau I
    Am J Gastroenterol; 2007 Dec; 102(12):2781-8. PubMed ID: 17900327
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fecal bacteriotherapy for recurrent Clostridium difficile infection.
    Bakken JS
    Anaerobe; 2009 Dec; 15(6):285-9. PubMed ID: 19778623
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metronidazole and vancomycin: equivalence of initial efficacy in CDAD.
    Burman LG
    Am J Gastroenterol; 2008 Aug; 103(8):2147; author reply 2147. PubMed ID: 18796117
    [No Abstract]   [Full Text] [Related]  

  • 14. [Antibiotic-induced diarrhea and pseudomembranous colitis].
    Schreiner A
    Nord Med; 1993; 108(11):283-5. PubMed ID: 8247717
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Occurrence and treatment of Clostridium difficile-associated diarrhea].
    Tvede M; Høiby N
    Ugeskr Laeger; 2006 Jun; 168(26-32):2579; author reply 2579-80. PubMed ID: 16824400
    [No Abstract]   [Full Text] [Related]  

  • 16. [Recurrent Clostridium difficile enterocolitis].
    Bergamin B; Hess T; Jost R; Ballmer PE; Imoberdorf R
    Schweiz Med Wochenschr; 2000 Nov; 130(44):1681-4. PubMed ID: 11103440
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Absence of pseudomembranes in Clostridium difficile-associated diarrhea in patients using immunosuppression agents.
    Nomura K; Fujimoto Y; Yamashita M; Morimoto Y; Ohshiro M; Sato K; Oyake T; Kowata S; Konishi H; Yoshikawa T; Ishida Y; Taniwaki M;
    Scand J Gastroenterol; 2009; 44(1):74-8. PubMed ID: 18781540
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metronidazole for Clostridium difficile-associated disease: is it okay for Mom?
    Gerding DN
    Clin Infect Dis; 2005 Jun; 40(11):1598-600. PubMed ID: 15889356
    [No Abstract]   [Full Text] [Related]  

  • 19. Beyond mainstream: making the case for fecal bacteriotherapy.
    Myers F
    Nursing; 2011 Dec; 41(12):50-3. PubMed ID: 22089910
    [No Abstract]   [Full Text] [Related]  

  • 20. Breaking the cycle: treatment strategies for 163 cases of recurrent Clostridium difficile disease.
    McFarland LV; Elmer GW; Surawicz CM
    Am J Gastroenterol; 2002 Jul; 97(7):1769-75. PubMed ID: 12135033
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 33.